
Browsing restrictions can be lifted for a fee.
No related data records
7759
視航生醫
-6.13%
(-0.06)
The most recent financial report for 視航生醫 (7759) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7759's short-term business performance and financial health. For the latest updates on 7759's earnings releases, visit this page regularly.
At the end of the period, 視航生醫 (7759) held Total Cash and Cash Equivalents of 255.22M, accounting for 0.45 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.